BackBiocure Technology Overview

Biocure Technology Receivables

Biocure Technology's receivables is $7.7K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$7674.00
↑ 58.91% YoYΔ $2845.00 vs prior year quarter

Peer trimmed avg / median

Loading

Biocure Technology Receivables History

Loading

Biocure Technology vs. peers: Receivables Comparison

Loading

Biocure Technology Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Biocure Technology (CURE.CN) FAQ

As of the most recent data (June 2025), CURE.CN shows a receivables of $7.7K. That compares with $4.8K in the prior-year period — up 58.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CURE.CN's receivables is now $7.7K (was $4.8K) — a 58.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biocure Technology is outperforming or lagging.

Tracking CURE.CN's receivables over time shows whether Biocure Technology is scaling, shrinking, or reshaping that part of the business. The current reading is $7.7K That compares with $4.8K in the prior-year period — up 58.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Biocure Technology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $7.7K) with ownership activity and broader fundamentals.

Biocure Technology's receivables is $7.7K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.